The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/22000
StudyName: Eligibility Lung Cancer NCT00452881
Date of export from the portal: 02.07.2020
Date of Upload / last change: 14.05.2017
License: Creative Commons BY 4.0

----

Description: 
Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC; ODM derived from: https://clinicaltrials.gov/show/NCT00452881
